Skip to main content
. 2022 Jun 7;51(9):2487–2497. doi: 10.1177/03635465221095563

Figure 7.

Figure 7.

(A) A subgroup analysis for endpoint VAS scores with a single versus multiple injections of PRP. (B) A subgroup analysis for endpoint VAS scores with a high versus low total dose of PRP. IV, inverse variance; PRP, platelet-rich-plasma; VAS, visual analog scale.